# Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

> **NCT04506398** · — · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Hepatocellular Carcinoma Recurrent
- Liver Transplant; Complications

## Interventions

- **PROCEDURE:** liver transplant
- **DIAGNOSTIC_TEST:** ctDNA
- **DIAGNOSTIC_TEST:** whole exome sequencing

## Key facts

- **NCT ID:** NCT04506398
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-10
- **Primary completion:** 2021-08
- **Final completion:** 2022-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04506398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04506398, "Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04506398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*